Connection

Shuyang Zhang to Antiviral Agents

This is a "connection" page, showing publications Shuyang Zhang has written about Antiviral Agents.
Connection Strength

0.145
  1. Safety profile of the antiviral drug remdesivir: An update. Biomed Pharmacother. 2020 10; 130:110532.
    View in: PubMed
    Score: 0.082
  2. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Nat Struct Mol Biol. 2021 03; 28(3):319-325.
    View in: PubMed
    Score: 0.022
  3. Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19). Chin Med J (Engl). 2020 11 02; 134(4):407-409.
    View in: PubMed
    Score: 0.021
  4. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science. 2020 06 26; 368(6498):1499-1504.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.